Arbeitspapier
The Effect of Intellectual Property Rights on Domestic Innovation in the Pharmaceutical Sector
This paper analyses the causal impact of Intellectual Property Rights (IPR) on pharmaceutical innovation in a panel of 74 countries. The identification strategy exploits the different timing across countries of two sets of IPR reforms. Domestic innovation is measured as citation-weighted domestic patents filed at the European Patent Office (EPO): to account for their distribution, count data models are used. A Zero Inated Negative Binomial model is adopted to consider the choice not to patent at the EPO. Results show that, in the short-run, IPR stimulate innovation. The effect for developing countries is roughly half of that for developed countries.
- Sprache
-
Englisch
- Erschienen in
-
Series: CESifo Working Paper ; No. 6004
- Klassifikation
-
Wirtschaft
Intellectual Property and Intellectual Capital
Innovation and Invention: Processes and Incentives
Health: Government Policy; Regulation; Public Health
Property Law
- Thema
-
intellectual property rights
developing countries
pharmaceutical sector
innovation
patents
TRIPS
- Ereignis
-
Geistige Schöpfung
- (wer)
-
Gamba, Simona
- Ereignis
-
Veröffentlichung
- (wer)
-
Center for Economic Studies and ifo Institute (CESifo)
- (wo)
-
Munich
- (wann)
-
2016
- Handle
- Letzte Aktualisierung
-
10.03.2025, 11:45 MEZ
Datenpartner
ZBW - Deutsche Zentralbibliothek für Wirtschaftswissenschaften - Leibniz-Informationszentrum Wirtschaft. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Objekttyp
- Arbeitspapier
Beteiligte
- Gamba, Simona
- Center for Economic Studies and ifo Institute (CESifo)
Entstanden
- 2016